69.23
Dexcom Inc (DXCM) 最新ニュース
DexCom Inc. stock daily chart insightsEarnings Risk Report & Weekly Watchlist for Consistent Profits - newser.com
Will breakout in DexCom Inc. lead to full recoveryEarnings Overview Summary & AI Driven Stock Movement Reports - newser.com
DXCM Investors Have Opportunity to Lead DexCom, Inc. Securities Fraud Lawsuit - Morningstar
DexCom (DXCM) Expands Board with Appointment of Dr. Euan Ashley - GuruFocus
DCXM ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of DexCom, Inc. Investors - The AI Journal
Rosen Law Firm Urges DexCom, Inc. (NASDAQ: DXCM) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - The AI Journal
Portnoy Law Firm Announces Class Action on Behalf of DexCom, Inc. Investors - GlobeNewswire
DexCom Faces New Reports Of Deaths Linked To G7 Glucose Monitor - Benzinga
DexCom (DXCM) Shares Dip as Hunterbrook Issues Short Report - GuruFocus
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed DexCom, Inc. (DXCM) - GlobeNewswire Inc.
Dexcom Shares Slide After Short Seller Flags 3 Additional Deaths From G7 Devices - Stocktwits
DexCom falls as Hunterbrook releases new short report (DXCM:NASDAQ) - Seeking Alpha
AstraZeneca non-executive director Euan Ashley joins DexCom board By Investing.com - Investing.com Nigeria
DexCom Shares Fall After Hunterbrook Report on Incidents Related to G7 Glucose Monitor - MarketScreener
Dexcom (DXCM) Faces Scrutiny Following Reports of Glucose Monito - GuruFocus
DexCom (DXCM) Shares Fall 2% Following Short Report - GuruFocus
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire
Can Dexcom Deliver Strong Q3 Earnings on Stelo Gains and G7 Adoption? - Yahoo Finance
AstraZeneca non-executive director Euan Ashley joins DexCom board - Investing.com
Can technical indicators confirm DexCom Inc.’s reversalPortfolio Update Report & Free Expert Verified Stock Movement Alerts - newser.com
DexCom: Powering The Future Of Glucose Monitoring And Digital Care - RTTNews
Is DexCom Inc. (DC4) stock a buy for dividend portfoliosTrade Analysis Summary & Verified Entry Point Detection - newser.com
What MACD trends signal for DexCom Inc. (DC4) stockJuly 2025 Breakouts & Reliable Trade Execution Plans - newser.com
What catalysts could drive DexCom Inc. stock higherTrade Exit Report & Consistent Profit Trading Strategies - newser.com
How DexCom Inc. stock performs in interest rate cyclesQuarterly Growth Report & Technical Entry and Exit Tips - Fundação Cultural do Pará
Is DexCom Inc. stock reversal real or fakeMarket Growth Report & Risk Managed Investment Entry Signals - newser.com
Can DexCom Inc. stock sustain free cash flow growthMarket Sentiment Review & Free Technical Pattern Based Buy Signals - newser.com
DexCom Inc. stock chart pattern explainedWeekly Profit Analysis & AI Based Trade Execution Alerts - newser.com
What does recent volatility data suggest for DexCom Inc.Watch List & Fast Gaining Stock Strategy Reports - newser.com
Will DexCom Inc. stock maintain momentum in 2025Quarterly Trade Summary & AI Forecasted Entry and Exit Points - newser.com
Dexcom appoints Stanford’s Euan Ashley to board of directors - Investing.com
Dexcom appoints Stanford’s Euan Ashley to board of directors By Investing.com - Investing.com Nigeria
Dexcom appoints Euan Ashley to board of directors - MarketScreener
Dexcom Appoints Euan Ashley To Board Of Directors - TradingView
Dexcom Appoints Euan Ashley to Board of Directors - The Joplin Globe
DexCom, Inc. Experiences Valuation Adjustment Amidst Competitive Market Landscape - Markets Mojo
Halper Sadeh LLC Encourages DexCom, Inc. Shareholders to Contact the Firm to Discuss Their Rights - The AI Journal
Is DexCom Inc. stock attractive for passive investorsDay Trade & Weekly Top Stock Performers List - newser.com
What MACD and RSI say about DexCom Inc.Portfolio Risk Summary & Free Technical Pattern Based Buy Signals - newser.com
Will a bounce in DexCom Inc. offer an exit2025 Volume Leaders & Long-Term Capital Growth Ideas - newser.com
大文字化:
|
ボリューム (24 時間):